Novartis steps in to compete with Mylan ’ s Epipen
Adamis Pharmaceuticals (NSDQ:ADMP) said this week that it inked an exclusive deal with Novartis‘ (NYSE:NVS) Sandoz unit to distribute and commercialize its Symjepi emergency allergy treatment. The agreement puts Novartis in the position to compete directly with Mylan‘s (NSDQ:MYL) EpiPen auto-injector. The pharma giant has been under pressure in recent months thanks to manufacturing delays that have caused an Epipen shortage in the U.S. Get the full story at our sister site, Drug Delivery Business News. The post Novartis steps in to compete with Mylan’s Epipen appeared first on MassDevice.
Ottogi America, Inc. announced today it is recalling below 21 items due to a possibility of containing egg ingredient undeclared on the packages. People who have an allergy or severe sensitivity to eggs run the risk of serious or life-threatening allergic reaction of they consume these products.
Publication date: Available online 17 January 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Timothy Craig, William Lumry, Marco Cicardi, Bruce Zuraw, Jonathan A. Bernstein, John Anderson, Joshua Jacobs, Marc A. Riedl, Michael E. Manning, Aleena Banerji, Richard G. Gower, Teresa Caballero, Henriette Farkas, Henrike Feuersenger, Iris Jacobs, Thomas Machnig, Hilary Longhurst, COMPACT Investigators
ConclusionsFDEIA is an increasingly recognised serious allergic disease. The clinical diagnosis is supported by targeted sensitisation testing and molecular-based allergy diagnostics. These tools allow implementation of effective dietary and lifestyle modifications that mitigate against future serious reactions. Given the limited access to physicians with specialist allergy training in Ireland, increased awareness of this condition amongst sports medicine specialists and general physicians is required.
AbstractPurpose of ReviewNatural killer cells are innate lymphoid cells (ILCs) that play critical roles in human host defense and are especially useful in combating viral pathogens and malignancy.Recent FindingsThe NK cell deficiency (NKD) is particularly underscored in patients with a congenital immunodeficiency in which NK cell development or function is affected. The classical NK cell deficiency (cNKD) is a result of absent or a profound decrease in the number of circulating NK cells. In contrast, functional NKD (fNKD) is characterized by abnormal NK cell function but with normal number of NK cells. The combined immune ...
AbstractPurpose of ReviewTelemedicine uses technology to connect patients and data with providers at a distance. Direct to consumer telemedicine is a rapidly growing segment of the industry.Recent FindingsThe telehealth market has skyrocketed in recent years, making it a multi-billion dollar industry. Direct to consumer telehealth, dominated by the for-profit private sector, is the most popular form.SummaryDirect to consumer telemedicine is a subset of telehealth that shows promise in increasing access to and engagement in medical care. Quality assurance, reimbursement, and regulatory oversight are important factors in ass...
Most patients who report having a penicillin allergy are not really allergic to the antibiotic, and they may be missing out on the best treatment for their condition as a result, according to a report in JAMA January 15.Reuters Health Information
The package appeared one day, unbidden, on the desk of a TIME writer. Inside was a slick white box that housed a petri dish sealed with gold tape. In the dish was a crumpled tissue—and inside the tissue were, allegedly, the germs of a sick person who had sneezed into it. Vaev Tissue, the only product of a new startup based in Los Angeles, costs $79.99, according to the company’s website. Its sole purpose is to give the user a cold virus. “We believe using a tissue that carries a human sneeze is safer than needles or pills,” read the note that came with the product, written by the founder of the comp...
Conditions: Overweight and Obesity; Allergy Intervention: Procedure: Vaginal seeding Sponsors: Peking University; National Natural Science Foundation of China; Liuyang Maternal and Child Health Care Hospital Recruiting
Conditions: Malaria; Febrile Illness Interventions: Other: Conditional ACT subsidy, Arm 1 levels; Other: Conditional ACT subsidy, Arm 2 levels; Other: Conditional ACT subsidy, Arm 3 levels; Other: Conditional ACT subsidy, Arm 4 levels Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID); Moi University; Clinton Health Access Initiative, Nigeria Not yet recruiting
“Cha-ching!” goes urgent care. For your rhinovirus, adenovirus, or seasonal allergies you get a strep screen, flu swab, CBC, and chest X-ray. You get a steroid shot, Rocephin, and Z-Pak. A week later, you present for medical care again, because your virus is no better, and you want a stronger an tibiotic. In the meantime, your […]Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Learn more.